Days of utilization , adherence ( proportion of days covered ≥0.8 ) , and discontinuation ( non-use for ≥30 days immediately prior to BP measurement ) of three statins ( atorvastatin , pravastatin , and simvastatin ) over a period of up to 2 years was monitored retrospectively from electronic databases .
Statin utilisation in a real-world setting: a retrospective analysis in relation to arterial and cardiovascular autonomic function. Randomized trials suggest that statin treatment may lower blood pressure and influence cardiovascular autonomic function (CVAF), but the impact of duration of usage, discontinuation, and adherence to this therapy is unknown. We examined these issues with regard to blood pressure (BP)-related variables in a large, population-based study. Participants were 4942 adults (58% male; aged 50-84 years): 2179 on statin treatment and 2763 untreated. Days of utilization , adherence ( proportion of days covered ≥0.8 ) , and discontinuation ( non-use for ≥30 days immediately prior to BP measurement ) of three statins ( atorvastatin , pravastatin , and simvastatin ) over a period of up to 2 years was monitored retrospectively from electronic databases . Systolic BP (SBP), diastolic BP (DBP), augmentation index, excess pressure, reservoir pressure, and CVAF (pulse rate and BP variability) parameters were calculated from aortic pressure waveforms derived from suprasystolic brachial measurement. Days of statin treatment had inverse relationships with pulse rate variability parameters in cardiac arrhythmic participants (20-25% lower than in statin non-users) and with most arterial function parameters in everyone. For example, compared to untreated participants, those treated for ≥659 days had 3.0 mmHg lower aortic SBP (
### Instruction:
            Given the context about compound efficacy for the given treatment mentioned within the input, mentioned the compounds 
            that can co-occur for the mentioned treatment

            ### Input:
            Statin utilisation in a real-world setting: a retrospective analysis in relation to arterial and cardiovascular autonomic function. Randomized trials suggest that statin treatment may lower blood pressure and influence cardiovascular autonomic function (CVAF), but the impact of duration of usage, discontinuation, and adherence to this therapy is unknown. We examined these issues with regard to blood pressure (BP)-related variables in a large, population-based study. Participants were 4942 adults (58% male; aged 50-84 years): 2179 on statin treatment and 2763 untreated. Days of utilization , adherence ( proportion of days covered ≥0.8 ) , and discontinuation ( non-use for ≥30 days immediately prior to BP measurement ) of three statins ( atorvastatin , pravastatin , and simvastatin ) over a period of up to 2 years was monitored retrospectively from electronic databases . Systolic BP (SBP), diastolic BP (DBP), augmentation index, excess pressure, reservoir pressure, and CVAF (pulse rate and BP variability) parameters were calculated from aortic pressure waveforms derived from suprasystolic brachial measurement. Days of statin treatment had inverse relationships with pulse rate variability parameters in cardiac arrhythmic participants (20-25% lower than in statin non-users) and with most arterial function parameters in everyone. For example, compared to untreated participants, those treated for ≥659 days had 3.0 mmHg lower aortic SBP (

            ### Response:
            atorvastatin, pravastatin, simvastatin
            